PAFSC’s 2nd Committee Receives Report on Add’l Indication for Xeloda, Elplat

November 2, 2015
The Second Committee on Drugs of the Pharmaceutical Affairs and Food Sanitation Council (PAFSC) received on October 29 reports on additional indications for drugs including Chugai Pharmaceutical’s Xeloda (capecitabine) and Yakult Honsha’s Elplat IV Infusion Solution 50 mg/100 mg/200 mg...read more